Pharma PR & Communications 2021
The global pandemic has spawned another variant: the COVID-19 infodemic — described as “a mix of evolving and conflicting findings, factual errors, rumors, and conspiracy theories, spread lightning-fast through all forms of media, often to promote political agendas rather than public health.”
Communicating around complex science and data in an era of politicization and distrust can be a challenge in any disease state. In this session, we’ll explore the changing environment, and the people and platforms that can help make a message trustworthy and transparent.
Date: Monday- October 4, 2021
Time: 1:30PM EDT
Speakers
Paul Tyahla
Executive Vice President of Risk and Reputation Management at Syneos Health Communications
He has led clients through issues related to pricing and access to medicines, high-profile regulatory milestones, supply chain disruptions, and media investigations. Prior to joining Syneos, Paul spent ten years in state-level public policy advocating on a range of health care related policies.
Peter Pitts
Visiting Professor at the University of Paris Medical School and President of the Center for Medicine in the Public Interest
He is a former member of the United States Senior Executive Service and Associate Commissioner of the US Food & Drug Administration. Pitts is a member of the Council for International Organizations of Medical Sciences (CIOMS) Expert Working Group to help advance patient involvement in the development and safe use of medicines. (CIOMS is an international, non-governmental, non-profit organization established jointly by WHO and UNESCO in 1949.)
He is the lead author of many professional peer reviewed publications including the Lancet, Therapeutic Innovation and Regulatory Science, and Nature Biotechnology. He is an Associate Editor of Therapeutic Innovation & Regulatory Science (the official DIA journal), a member of the External Advisory Board, IMS Institute for Healthcare Informatics in Asia, Executive Advisory Board, the Galien Foundation, Editorial Advisory Board, Food and Drug Policy Forum, Advisory Board, Journal of Commercial Biotechnology and a member of the Editorial Advisory Board of The Patient Magazine. Pitts lives in New York City.
His new book is The Value Equation: A. Journey Through the Innovation Ecosystem in the Time of COVID. He is also the author of Common-Sense Healthcare for Common Sense Americans and Become Strategic or Die, widely recognized as a cutting- edge study of how leadership, in order to be successful over the long term, must be combined with strategic vision and ethical practice. He is the editor of Coincidence or Crisis, a discussion of global prescription medicine counterfeiting and Physician Disempowerment: A Transatlantic Malaise.
A graduate of McGill University, he is married to Jane Mogel, and has two sons.
